GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹4,923 Cr | ₹3,328 Cr | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr |
What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹4,923 Cr |
| Mar2025 | ₹3,328 Cr |
| Mar2024 | ₹1,609 Cr |
| Mar2023 | ₹3,877 Cr |
| Mar2022 | ₹3,593 Cr |
How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,923 Cr | 47.92 | |
| Mar2025 | ₹3,328 Cr | 106.80 | |
| Mar2024 | ₹1,609 Cr | -58.49 | |
| Mar2023 | ₹3,877 Cr | 7.92 | |
| Mar2022 | ₹3,593 Cr | - | |
Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,398.0 Cr | -0.3% | -6.5% | 16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.3% |
-6.5% |
16.2% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses